Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
10/19/2000 | WO2000061608A2 Low-molecular inhibitors of complement proteases |
10/19/2000 | WO2000061604A2 Pharmaceutical compounds |
10/19/2000 | WO2000061586A1 Bicyclic heteroaromatic compounds useful as lh agonists |
10/19/2000 | WO2000061582A1 Substituted fused imidazole derivatives |
10/19/2000 | WO2000061542A1 Caspase inhibitors and the use thereof |
10/19/2000 | WO2000061541A2 Pharmaceutical compounds |
10/19/2000 | WO2000061539A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
10/19/2000 | WO2000042992A3 Compositions and methods for mucosal delivery |
10/19/2000 | WO2000041505A3 Anthranilic acid derivatives |
10/19/2000 | WO2000032224A3 Calcitonin for the modulation of sperm function |
10/19/2000 | WO2000012720A8 Elongase genes and uses thereof |
10/19/2000 | DE19917930A1 Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity |
10/19/2000 | DE19915601A1 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-3-arylpropan-1-ol-derivatives, their preparation and use |
10/19/2000 | CA2370425A1 Pharmaceutical compounds |
10/19/2000 | CA2369619A1 Caspase inhibitors and the use thereof |
10/19/2000 | CA2369378A1 Low-molecular inhibitors of complement proteases |
10/19/2000 | CA2369262A1 Pulmonary administration of dry powder formulations for treating infertility |
10/19/2000 | CA2369029A1 Poly(dipeptide) as a drug carrier |
10/19/2000 | CA2368840A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
10/19/2000 | CA2365910A1 Human proteins and polynucleotides encoding them |
10/18/2000 | EP1044972A1 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVE AND DRUGS CONTAINING THE SAME |
10/18/2000 | EP1044970A1 Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them |
10/18/2000 | EP1043993A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
10/18/2000 | CN1270585A Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
10/18/2000 | CN1270527A Use of neurotoxin therapy for treatment of urologic and related disorders |
10/18/2000 | CN1270521A Oral contraceptive preparation having a first phase comprising comprising progestin/estrogen and a second phase comprising progestin |
10/18/2000 | CN1270514A Pharmaceutical composition for treating dymenorrhea and premature labor |
10/18/2000 | CN1270162A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
10/18/2000 | CN1270052A Medicinal composition for relieving sexual fatigue and delaying sanility and preparing process thereof |
10/18/2000 | CN1270037A Powdered Chinese medicine and its preparing process |
10/18/2000 | CN1057460C Fukang granule for women and its prepn. |
10/18/2000 | CN1057459C Nutritive liquid for male |
10/18/2000 | CN1057457C Mongolian medicine for curing venereal disease |
10/18/2000 | CN1057452C Pellet for generation of semen |
10/18/2000 | CN1057446C Active lactobacillus capsule |
10/17/2000 | US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
10/17/2000 | US6133269 Polymorphic form of doxazosin mesylate (form II) |
10/17/2000 | US6133251 First stage daily dosage portion is natural estrogen, second stage daily dosage portion is a combination of natural estrogen and natural or synthetic gestogen, third stage daily dosage portion is natural estrogen, fourth dosage is placebo |
10/17/2000 | US6132720 Immunogens against gonadotropin releasing hormone |
10/15/2000 | CA2305940A1 Aminotriazol compounds, the process for preparing them and the pharmaceutical compositions containing them |
10/12/2000 | WO2000060082A2 Vesicle associated proteins |
10/12/2000 | WO2000059946A1 Hydroxymatairesinol in cancer prevention |
10/12/2000 | WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
10/12/2000 | WO2000059899A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
10/12/2000 | WO2000059886A2 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors |
10/12/2000 | WO2000059855A1 Ether compounds, compositions, and uses thereof |
10/12/2000 | WO2000059851A1 Derivatives of venlafaxine and methods of preparing and using the same |
10/12/2000 | WO2000059577A1 Low dose estrogen interrupted hormone replacement therapy |
10/12/2000 | WO2000059547A2 Method of detecting endometriosis |
10/12/2000 | WO2000059545A1 Modification of sexual behaviour in animals and pest control |
10/12/2000 | WO2000059542A1 Method for a programmed controlled ovarian stimulation protocol |
10/12/2000 | WO2000059527A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
10/12/2000 | WO2000059512A1 Formulation comprising testosteron undecanoate and castor oil |
10/12/2000 | WO2000059495A1 (e)-styryl sulfone anticancer agents |
10/12/2000 | WO2000059491A2 Methods for modulating the human sexual response |
10/12/2000 | WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
10/12/2000 | WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
10/12/2000 | WO2000059447A2 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
10/12/2000 | WO2000020027A3 Methods for therapeutic vaccination |
10/12/2000 | CA2369544A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives:selective modulators of bradykinin b2 receptors |
10/12/2000 | CA2369071A1 Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them |
10/12/2000 | CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
10/12/2000 | CA2368387A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
10/12/2000 | CA2368083A1 Derivatives of venlafaxine and methods of preparing and using the same |
10/12/2000 | CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
10/12/2000 | CA2366903A1 Methods for modulating the human sexual response |
10/12/2000 | CA2366774A1 Method of detecting endometriosis |
10/12/2000 | CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
10/12/2000 | CA2365421A1 Vesicle associated proteins |
10/12/2000 | CA2361885A1 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
10/11/2000 | EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use |
10/11/2000 | EP1043028A1 Method for preventing/remedying mastitis |
10/11/2000 | EP1042674A1 148 human secreted proteins |
10/11/2000 | EP1042353A1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives |
10/11/2000 | EP1042352A1 Androgenic steroid compounds and a method of making and using the same |
10/11/2000 | EP1042329A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical, compositions containing them and use for preparing medicines |
10/11/2000 | EP1042325A1 Nitrogen-containing heterocyclic compounds, their production and use |
10/11/2000 | EP1041880A1 A delivery of arginine to cause beneficial effects |
10/11/2000 | EP0937101B1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them |
10/11/2000 | CN1269833A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
10/11/2000 | CN1269719A Aroylpiperazines for modulating sexual activity |
10/11/2000 | CN1269717A Therapeutical system for transdermal delivery of leconorgestrel |
10/11/2000 | CN1269213A The active part of golden pheasant as one Chinese medicine material and its application in preparing medicinal composite |
10/11/2000 | CN1057305C Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceuticals |
10/11/2000 | CN1057295C Sulfonamide endothelin antagonists and use thereof |
10/10/2000 | US6130223 Thienopyrimidine with phosphodiesterase V inhibiting effect |
10/10/2000 | US6130218 High blood pressure |
10/10/2000 | US6130216 Use of thiazolidinedione derivatives in the treatment of insulin resistance |
10/10/2000 | US6130204 Peptides |
10/10/2000 | US6130064 Amino acid sequence encoded by polynucleotide from survival motor neuron gene; diagnosis, treatment, and prevention of nervous system, reproductive, and cell proliferative disorders; antiproliferative/anticarcinogenic agents |
10/10/2000 | US6130062 Production of proteins in host cells |
10/10/2000 | CA2020346C Antibiotic ge 2270 factors a1, a2, a3 and h |
10/07/2000 | CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use |
10/05/2000 | WO2000058361A1 Melanocortin receptor ligands |
10/05/2000 | WO2000058350A1 49 human secreted proteins |
10/05/2000 | WO2000058339A2 50 human secreted proteins |
10/05/2000 | WO2000058277A1 Aryl sulfonic acids and derivatives as fsh antagonists |
10/05/2000 | WO2000057920A2 Method for expressing proteins |
10/05/2000 | WO2000032178A3 Use of siburamine for the treatment of disorders of the central nervous system secondary to organic impairments |
10/05/2000 | WO2000032171A3 Autoahesive oral transmucosal delivery dosage form |